V

Veru
D

VERU

0.67440
USD
0.05
(7.34%)
Market Closed
Volume
37,395
EPS
-0
Div Yield
-
P/E
-2
Market Cap
98,721,316
OverviewSignalsIdeasNews
Related Instruments
    A
    ACOR
    -0.26810
    (-30.48%)
    0.61160 USD
    A
    AGEN
    -0.05000
    (-1.80%)
    2.72500 USD
    A
    ALRN
    -0.47000
    (-14.20%)
    2.84000 USD
    C
    CTMX
    -0.08670
    (-8.67%)
    0.91330 USD
    E
    ESPR
    0.03000
    (1.43%)
    2.13000 USD
    L
    LPCN
    -0.32000
    (-6.14%)
    4.89000 USD
    T
    TRVN
    -2.02000
    (-44.99%)
    2.47000 USD
    V
    VKTX
    -3.960
    (-7.39%)
    49.620 USD
    Z
    ZYNE
    0
    (0%)
    0.000000 USD
    More
News

Title: Veru

Sector: Healthcare
Industry: Biotechnology
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.